Development of a Novel Fully Functional Coagulation Factor VIII with Reduced Immunogenicity Utilizing an In silico Prediction and Deimmunization Approach by Riley Nolan | Jun 8, 2021
Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains by Riley Nolan | Jun 8, 2021
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation by Riley Nolan | May 13, 2021
Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival by Riley Nolan | May 13, 2021
Human antibody immune responses are personalized by selective removal of MHC-II peptide epitopes by Riley Nolan | Mar 23, 2021Human antibody immune responses are personalized by selective removal of MHC-II peptide epitopes